Blog - News

The PCI team never stops innovating. Stay informed about our latest achievements.

Times Have Changed: Coronavirus Bares Drug Supply Dangers

Tags: API Manufacturing | Blog | Congress | Drug Shortage | Generic Drug Manufacturing | SEQENS

Posted March 30, 2020
Antibiotic Innovation Begins with Making It Easier for Manufacturers to Stay in Business

Tags: Blog | epidemics | Superbugs

Posted March 23, 2020
How Do You Manage Corporate Risk in Drug Substance Manufacturing?

Tags: API Manufacturing | Blog | CDMO | risk management

Posted March 11, 2020
Avoiding FDA Drug Rescissions: Sponsors Seek CDMOs With Strong Regulatory Track Records

Tags: API Manufacturing | Blog | FDA | GDUFA

Posted February 24, 2020
How Well Do You Know Your CDMO’s Manufacturing Capacity?

Tags: API Manufacturing | Blog | Equipment | Impurities

Posted February 10, 2020
Things You Should Know About Phase 1 API Manufacturing

Tags: API Manufacturing | Blog | Quality Systems

Posted February 3, 2020
Shattering Five Myths about CDMOs

Tags: API Manufacturing | Blog | CDMO

Posted January 24, 2020
Key Considerations When Manufacturing APIs for Injectables

Tags: Blog | CDMO | injectables

Posted January 13, 2020
Opportunities Created by the Growing Convergence of Food and Pharmaceuticals

Tags: Blog | Pharma Food

Posted January 6, 2020
Demand Uncertainty? Why More Pharmaceutical Companies are Turning to More Flexible CDMOs

Tags: API Manufacturing | Blog | Targeted Therapies

Posted December 28, 2019